RESEARCH CASE STUDY Role of Exercise in Metabolic Associated Fatty Liver Disease (Filmed 2024)
Dr. Shelley Keating AES AEP* is an Accredited Exercise Physiologist, a researcher, and a senior lecturer at the School of Human Movement and Nutrition Sciences at the University of Queensland in Brisbane, Australia. Dr. Keating’s research primarily focuses on the role of exercise in the management of metabolic dysfunction associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease. MASLD affects a significant portion of the global adult population, with many individuals unaware of their condition.
The condition is strongly linked with the development of Type 2 diabetes, heart disease, and various liver-related consequences. Dr. Keating’s research emphasises lifestyle interventions, particularly the role of exercise, in managing MASLD. Her work has shown that aerobic exercise, independent of weight loss, plays a crucial role in reducing liver fat and improving liver health.
Through clinical trials, Dr. Keating and her team have explored the impact of different doses of supervised aerobic exercise on individuals with obesity and MASLD. Their findings suggest that aerobic exercise, at various durations and intensities, yields benefits for reducing liver fat. They recommend 150 to 240 minutes of moderate to vigorous intensity aerobic exercise per week as beneficial for improving liver health. Moreover, even lower doses of exercise, such as 135 minutes per week, have shown positive effects.
Dr. Keating has collaborated with Exercise and Sports Science Australia and international experts in creating exercise guidelines for the management of MASLD, which have been adopted in numerous policies and guidelines worldwide. Currently, her focus is on designing tailored exercise solutions to help individuals living with MASLD sustain long-term exercise behaviours based on their needs, perspectives, and experiences.
* AES is the acronym for Accredited Exercise Scientist (AES), AEP is the acronym for Accredited Exercise Physiologist
-
Vaccine effectiveness against infections triggering autoimmune disease
Dr Deborah Burnett is a Scientia Senior Lecturer and Laboratory Head at UNSW, where she leads a multidisciplinary research program spanning mechanistic immunology and translational vaccinology. Her work focuses on understanding how immune responses can protect against challenging infectious threats, including bacterial infections and infections associated with autoimmune disease.
-
Prescribing exercise to regional population with cardiovascular disease & diabetes
Associate Professor Gordon’s research is aimed at determining the optimal methods of prescribing and implementing exercise as part of the health care plan for people with cardiovascular disease and diabetes. Specifically, he is leading work to determine if and how the components of exercise can be considered as a whole for prescribing exercise to generate health benefits. This is important to overcome the series of barriers that people living in rural and regional areas experience when trying to become active.
-
Next Generation Condom Contraception, Dr David Shepherd
Dr David Shepherd is a Lead Production Engineer and Materials Specialist at Eudaemon Technologies. His journey began at the University of Wollongong, where he pursued advanced studies and eventually obtained a PhD under the guidance of a distinguished professor. His research initially focused on actuating materials and artificial muscles, particularly centred around hydrogel materials. These early explorations have seamlessly evolved into his current focus on utilising hydrogels in the realm of sexual reproductive health, with a specific emphasis on developing innovative hydrogel condoms.
